Literature DB >> 17153467

Intraoperative frozen section margin evaluation in gastric cancer of the cardia surgery.

Jian Guo Shen1, Jae Ho Cheong, Woo Jin Hyung, Junuk Kim, Seung Ho Choi, Sung Hoon Noh.   

Abstract

BACKGROUND/AIMS: The use of intraoperative frozen section to determine the extent of margin resection is a common practice. Our aim was to identify the value of intraoperative frozen section in margin evaluation and to investigate its indication for gastric cancer of the cardia.
METHODOLOGY: Intraoperative frozen section examinations of the proximal margins of 66 patients with gastric adenocarcinoma of the cardia were reviewed. The frozen section results were compared with those of the permanent sections. Clinicopathological features that predict a positive frozen section margin were examined by univariate and multivariate analysis.
RESULTS: The overall accuracy, sensitivity and specificity of an intraoperative frozen section, was 97%, 77.8%, and 100%, respectively. Infiltration on frozen section occurred in 10.7% (7/66) of the proximal margins, while in 28.6% (2/7) of the entire additional resection margins. The positive margins were associated with more advanced in depth of tumor invasion and disease stage. However, the depth of invasion was the only independent predictor for a positive frozen margin.
CONCLUSIONS: Routine evaluation of the proximal resection margin by intraoperative frozen section does not appear to be necessary in gastric cancer surgery of the cardia. However, this technique is advisable for patients with T3 or T4 lesions.

Entities:  

Mesh:

Year:  2006        PMID: 17153467

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

Review 1.  [R1 resection for gastric carcinoma].

Authors:  K Ridwelski; J Fahlke; M Huß; R Otto; S Wolff
Journal:  Chirurg       Date:  2017-09       Impact factor: 0.955

2.  Gastrectomy case volume and textbook outcome: an analysis of the Population Registry of Esophageal and Stomach Tumours of Ontario (PRESTO).

Authors:  Jordan Levy; Vaibhav Gupta; Elmira Amirazodi; Catherine Allen-Ayodabo; Naheed Jivraj; Yunni Jeong; Laura E Davis; Alyson L Mahar; Charles De Mestral; Olli Saarela; Natalie Coburn
Journal:  Gastric Cancer       Date:  2019-11-04       Impact factor: 7.370

3.  Molecular assessment of surgical-resection margins of gastric cancer by mass-spectrometric imaging.

Authors:  Livia S Eberlin; Robert J Tibshirani; Jialing Zhang; Teri A Longacre; Gerald J Berry; David B Bingham; Jeffrey A Norton; Richard N Zare; George A Poultsides
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

4.  Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study.

Authors:  Massimiliano Bissolati; Matteo Desio; Fausto Rosa; Stefano Rausei; Daniele Marrelli; Gian Luca Baiocchi; Giovanni De Manzoni; Damiano Chiari; Giovanni Guarneri; Fabio Pacelli; Lorenzo De Franco; Sarah Molfino; Chiara Cipollari; Elena Orsenigo
Journal:  Gastric Cancer       Date:  2016-01-05       Impact factor: 7.370

5.  Clinical importance and surgical decision-making regarding proximal resection margin for gastric cancer.

Authors:  Doosup Shin; Sung-Soo Park
Journal:  World J Gastrointest Oncol       Date:  2013-01-15

6.  Pancreatic Cancer Surgical Resection Margins: Molecular Assessment by Mass Spectrometry Imaging.

Authors:  Livia S Eberlin; Katherine Margulis; Ivette Planell-Mendez; Richard N Zare; Robert Tibshirani; Teri A Longacre; Moe Jalali; Jeffrey A Norton; George A Poultsides
Journal:  PLoS Med       Date:  2016-08-30       Impact factor: 11.069

7.  Population-Based Study on Risk Factors for Tumor-Positive Resection Margins in Patients with Gastric Cancer.

Authors:  Leonie R van der Werf; Charlotte Cords; Ivo Arntz; Eric J T Belt; Ivan M Cherepanin; Peter-Paul L O Coene; Erwin van der Harst; Joos Heisterkamp; Barbara S Langenhoff; Bas Lamme; Mark I van Berge Henegouwen; Sjoerd M Lagarde; Bas P L Wijnhoven
Journal:  Ann Surg Oncol       Date:  2019-04-22       Impact factor: 5.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.